Shree Ganesh Biotech (India) (BOM:539470) Total Equity: ₹636.33 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539470 Shree Ganesh Biotech (India) Ltd BOM:539470
43 GF Score
Price ₹0.56
GF Value ₹0.19
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shree Ganesh Biotech (India) Total Equity?

Shree Ganesh Biotech (India) BOM:539470 43 Total Equity is ₹636.33 Mil as of Mar. 2026. GuruFocus rates BOM:539470 with a GF Score™ of 43/100 and a GF Value™ of ₹0.19 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Shree Ganesh Biotech (India)'s total equity for the quarter that ended in Mar. 2026 was ₹636.33 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shree Ganesh Biotech (India) Total Equity Historical Data

* Premium members only.

The historical data trend for Shree Ganesh Biotech (India)'s Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Ganesh Biotech (India) Total Equity Chart

Shree Ganesh Biotech (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 603.18 623.57 629.78 632.56 636.33

Shree Ganesh Biotech (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 632.56 0.00 635.97 0.00 636.33
BOM:539470
43GF Score
Shree Ganesh Biotech (India) Ltd BOM:539470
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Ganesh Biotech (India) Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shree Ganesh Biotech (India)'s Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=638.029-1.695
=636.33

Shree Ganesh Biotech (India)'s Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=638.029-1.695
=636.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹636.33 Mil mean?
Shree Ganesh Biotech (India) (BOM:539470) has a Total Equity of ₹636.33 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Shree Ganesh Biotech (India) and its competitors.
Is Shree Ganesh Biotech (India)'s Total Equity too high?
Shree Ganesh Biotech (India)'s current Total Equity is ₹636.33 Mil. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s Total Equity compare to CTVA and CF?
Shree Ganesh Biotech (India)'s Total Equity of ₹636.33 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for an Agriculture company?
A good Total Equity depends on the Agriculture industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shree Ganesh Biotech (India) and its competitors. Shree Ganesh Biotech (India)'s current Total Equity is ₹636.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.19, compared to a current price of ₹0.56 — trading 194.7% above its estimated fair value. The current Total Equity is ₹636.33 Mil. Shree Ganesh Biotech (India)'s overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current Total Equity is ₹636.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued. The current stock price of ₹0.56 is trading 194.7% above its estimated GF Value™ of ₹0.19. GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.

Key valuation signals for BOM:539470:

  • Total Equity: ₹636.33 Mil
  • GF Value™: ₹0.19 vs. price of ₹0.56 (194.7% above fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Ganesh Biotech (India) Business Description

Address Cubicle No.:126,3/2 ,75C,Park Street, 3rd Floor, Kamdhenu Building, Kolkata, WB, IND, 700016
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
43GF Score

Get the complete analysis for BOM:539470

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.56
Price
₹0.19
GF Value